Literature DB >> 28657335

Immunometabolic Regulation of Vascular Redox State: The Role of Adipose Tissue.

Evangelos K Oikonomou1, Charalambos Antoniades1.   

Abstract

SIGNIFICANCE: Vascular oxidative stress plays a crucial role in atherogenesis and cardiovascular disease (CVD). Recent evidence suggests that vascular redox state is under the control of complex pathophysiological mechanisms, ranging from inflammation to obesity and insulin resistance (IR). Recent Advances: Adipose tissue (AT) is now recognized as a dynamic endocrine and paracrine organ that secretes several bioactive molecules, called adipokines. AT has recently been shown to regulate vascular redox state in both an endocrine and a paracrine manner through the secretion of adipokines, therefore providing a mechanistic link for the association between obesity, IR, inflammation, and vascular disease. Importantly, AT behaves as a sensor of cardiovascular oxidative stress, modifying its secretory profile in response to cardiovascular oxidative injury. CRITICAL ISSUES: The present article presents an up-to-date review of the association between AT and vascular oxidative stress. We focus on the effects of individual adipokines on modulating reactive oxygen species production and scavenging in the vascular wall. In addition, we highlight how inflammation, obesity, and IR alter the biology and secretome of AT leading to a more pro-oxidant phenotype with a particular focus on the local regulatory mechanisms of perivascular AT driven by vascular oxidation. FUTURE DIRECTIONS: The complex and dynamic biology of AT, as well as its importance in the regulation of vascular redox state, provides numerous opportunities for the development of novel, targeted treatments in the management of CVD. Therapeutic modulation of AT biology could improve vascular redox state affecting vascular disease pathogenesis. Antioxid. Redox Signal. 29, 313-336.

Entities:  

Keywords:  adipose tissue; cardiovascular disease; diabetes; inflammation; obesity; oxidative stress

Mesh:

Year:  2017        PMID: 28657335     DOI: 10.1089/ars.2017.7017

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  6 in total

Review 1.  Pathophysiology of cardiovascular disease in diabetes mellitus.

Authors:  Gerardo Rodriguez-Araujo; Hironori Nakagami
Journal:  Cardiovasc Endocrinol Metab       Date:  2018-02-14

2.  Adipose tissue-derived WNT5A regulates vascular redox signaling in obesity via USP17/RAC1-mediated activation of NADPH oxidases.

Authors:  Ioannis Akoumianakis; Fabio Sanna; Marios Margaritis; Ileana Badi; Nadia Akawi; Laura Herdman; Patricia Coutinho; Harry Fagan; Alexios S Antonopoulos; Evangelos K Oikonomou; Sheena Thomas; Amy P Chiu; Surawee Chuaiphichai; Christos P Kotanidis; Constantinos Christodoulides; Mario Petrou; George Krasopoulos; Rana Sayeed; Lei Lv; Ashley Hale; Meisam Naeimi Kararoudi; Eileen McNeill; Gillian Douglas; Sarah George; Dimitris Tousoulis; Keith M Channon; Charalambos Antoniades
Journal:  Sci Transl Med       Date:  2019-09-18       Impact factor: 17.956

Review 3.  The role of adipose tissue in cardiovascular health and disease.

Authors:  Evangelos K Oikonomou; Charalambos Antoniades
Journal:  Nat Rev Cardiol       Date:  2019-02       Impact factor: 32.419

Review 4.  State-of-the-art review article. Atherosclerosis affecting fat: What can we learn by imaging perivascular adipose tissue?

Authors:  Charalambos Antoniades; Christos P Kotanidis; Daniel S Berman
Journal:  J Cardiovasc Comput Tomogr       Date:  2019-03-29

Review 5.  Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk.

Authors:  Manuel F Landecho; Carlota Tuero; Víctor Valentí; Idoia Bilbao; Magdalena de la Higuera; Gema Frühbeck
Journal:  Nutrients       Date:  2019-11-05       Impact factor: 5.717

Review 6.  Reactive oxygen species (ROS) as pleiotropic physiological signalling agents.

Authors:  Helmut Sies; Dean P Jones
Journal:  Nat Rev Mol Cell Biol       Date:  2020-03-30       Impact factor: 113.915

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.